Current pharmacotherapeutic concepts for the treatment of obesity in adults

Therapeutic Advances in Cardiovascular Disease
Evgeny IdelevichChristoph Schindler

Abstract

Obesity is one of the greatest public health challenges of the twenty-first century. The World Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were overweight and at least 400 million adults were obese. The prevalence of obesity is still continuing to increase dramatically. Overweight and obese people carry a higher risk for a variety of cardiovascular diseases including hypertension, coronary heart disease, stroke and peripheral occlusive artery disease. Weight loss is considered to be the initial step which helps to prevent or to control the clinical consequences of obesity. In a great number of patients who are not able to reduce weight by means of non-pharmacological measures, drug therapy can assist in reaching the weight management targets. Drug treatment should only be considered as part of a systematic weight management program including dietary and lifestyle changes. This review summarizes current pharmacotherapeutic concepts for the treatment of obesity in adults focusing on efficacy and safety of anti-obesity drugs.

References

Jan 1, 1992·The American Journal of Clinical Nutrition·J B HauptmanD Hartmann
Nov 11, 1989·Lancet·B Guy-GrandP Turner
Aug 28, 1997·The New England Journal of Medicine·H M ConnollyH V Schaff
Oct 27, 1998·Journal of the American Dietetic Association·J M RippeR Ringer
Jan 26, 1999·JAMA : the Journal of the American Medical Association·M H DavidsonS B Heymsfield
Oct 8, 1999·American Journal of Public Health·G OsterG A Colditz
Apr 11, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·N FinerG Williams
Feb 15, 2001·Archives of Internal Medicine·T A WaddenC Steinberg
Sep 19, 2001·JAMA : the Journal of the American Medical Association·A Wirth, J Krause
Oct 12, 2001·Obesity Research·B MittendorferS Klein
Oct 31, 2001·The American Journal of Clinical Nutrition·J W AndersonC L Wood
Jul 20, 2002·Pharmacotherapy·Jennifer R McDuffieJack A Yanovski
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Katherine M FlegalClifford L Johnson
Dec 28, 2002·Diabetes Care·Steven J McNultyUNKNOWN Multicenter Sibutramine Study Group
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Kevin R FontaineDavid B Allison
Jan 28, 2003·Lancet·Joachim SprangerAndreas F H Pfeiffer
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·David S Weigle
Sep 17, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·R PadwalD C W Lau
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Tobias PischonEric B Rimm
May 6, 2004·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·H HaunerUNKNOWN SAT Study
May 12, 2004·Archives of Internal Medicine·David E ArterburnDavid L Veenstra
Jul 22, 2004·The Cochrane Database of Systematic Reviews·R PadwalD C W Lau
Aug 18, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·P BramlageA M Sharma
Sep 2, 2004·Nature Reviews. Drug Discovery·Vincenzo Di MarzoLuciano De Petrocellis
Oct 12, 2004·Endocrine Research·Ramazan SariUmit Karayalcin
Oct 16, 2004·American Journal of Hypertension·Peter BramlageArya M Sharma
Dec 8, 2004·Surgical Endoscopy·S SauerlandUNKNOWN European Association for Endoscopic Surgery

❮ Previous
Next ❯

Citations

Apr 12, 2012·Pflügers Archiv : European journal of physiology·Justin L GrobeCurt D Sigmund
Oct 2, 2009·Current Diabetes Reports·Jamie R Robinson, Kevin D Niswender
Nov 11, 2011·Science Translational Medicine·Kirstin F BarnhartRenata Pasqualini
Jan 1, 2010·ClinicoEconomics and Outcomes Research : CEOR·Armineh Zohrabian
Mar 25, 2011·Journal of Toxicology and Environmental Health. Part a·C J AmuzieJ J Pestka
Jul 31, 2013·Journal of Clinical Lipidology·Harold E BaysVarman T Samuel
Mar 6, 2010·Gastroenterology Clinics of North America·Lee M Kaplan
Aug 24, 2013·Diabetes, Obesity & Metabolism·M ChiltonL J Gray
Jan 5, 2011·Journal of Obesity·Lisa L Ioannides-DemosJohn J McNeil
Sep 24, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·A J Scheen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Ayca KayaCem Ekmekcioglu
Clinics in Dermatology
Yvonne Linné, Stephan Rössner
Current Drug Targets. CNS and Neurological Disorders
Steven V Joyal
© 2021 Meta ULC. All rights reserved